• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effects of micronized purified flavonoid fraction (Daflon) on pelvic pain in women with laparoscopically diagnosed pelvic congestion syndrome: a randomized crossover trial.

作者信息

Simsek M, Burak F, Taskin O

机构信息

Department of Obstetrics and Gynecology, Akdeniz University, Antalya, Turkey.

出版信息

Clin Exp Obstet Gynecol. 2007;34(2):96-8.

PMID:17629162
Abstract

BACKGROUND

We evaluated the effects of daflon, a venomimetic agent that regulates the circulatory tonus of the venous system, on pelvic pain and investigated the role of enlarged veins in the pathophysiology of pelvic congestion syndrome.

METHODS

Twenty women (age 28-35 yrs) with chronic pelvic pain were diagnosed with the syndrome at laparoscopy. They all had prominent broad ligaments and ovarian veins without other pathologies such as endometriosis to explain the etiology of pelvic pain. Ten women were randomized in a fashion to receive 500 mg of Daflon twice/daily for six months, and ten a vitamin pill for placebo effect; they were crossed over for another six months.

RESULTS

At the end of the third month, the frequency and severity of pelvic symptoms began to decrease with daflon compared with the pretreatment and vitamin arm. The mean scores were significantly less at the end of six months, respectively, p < 0.05.

CONCLUSIONS

Pharmacologic enhancement of venous tonus may restore pelvic circulation and relieve pelvic symptomatology.

摘要

相似文献

1
Effects of micronized purified flavonoid fraction (Daflon) on pelvic pain in women with laparoscopically diagnosed pelvic congestion syndrome: a randomized crossover trial.
Clin Exp Obstet Gynecol. 2007;34(2):96-8.
2
The Effects of Daflon on Pelvic Pain in Women with Taylor Syndrome.达芙通对泰勒综合征女性盆腔疼痛的影响。
J Am Assoc Gynecol Laparosc. 1996 Aug;3(4, Supplement):S49.
3
[Micronized purified flavonoid fraction in treatment of pelvic varicose veins].微粉化纯化黄酮类成分治疗盆腔静脉曲张
Angiol Sosud Khir. 2012;18(1):71-5.
4
Medical treatment for pelvic congestion syndrome with flavonoid: A pilot study.黄酮类化合物治疗盆腔淤血综合征的初步研究。
Taiwan J Obstet Gynecol. 2025 Mar;64(2):293-297. doi: 10.1016/j.tjog.2024.12.008.
5
Effectiveness and safety of micronized purified flavonoid fraction for the treatment of concomitant varicose veins of the pelvis and lower extremities.微粉化纯化黄酮类混合物治疗盆腔和下肢伴发性静脉曲张的有效性和安全性。
Curr Med Res Opin. 2019 Jun;35(6):1019-1026. doi: 10.1080/03007995.2018.1552043. Epub 2018 Dec 20.
6
Efficacy of micronized purified flavonoid fraction (Daflon®) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials.微粉化纯化黄酮类化合物(达芙通®)改善慢性静脉疾病患者个体症状、体征及生活质量的疗效:一项随机双盲安慰剂对照试验的系统评价与荟萃分析
Int Angiol. 2018 Apr;37(2):143-154. doi: 10.23736/S0392-9590.18.03975-5. Epub 2018 Jan 31.
7
The effect of a flavonoid mixture containing diosmin, hesperidin and troxerutin in women with congestion syndrome associated to pelvic pain: a color Doppler ultrasonography study.含地奥司明、橙皮苷和曲克芦丁的类黄酮混合物对伴有盆腔疼痛的充血综合征女性的影响:一项彩色多普勒超声研究。
Minerva Obstet Gynecol. 2024 Jun;76(3):250-256. doi: 10.23736/S2724-606X.24.05432-0.
8
[Current echography diagnosis of pelvic congestion syndrome].[盆腔淤血综合征的当前超声诊断]
Akush Ginekol (Sofiia). 2012;51 Suppl 1:10-5.
9
Pelvic congestion syndrome and pelvic varicosities.盆腔淤血综合征与盆腔静脉曲张
Tech Vasc Interv Radiol. 2014 Jun;17(2):90-5. doi: 10.1053/j.tvir.2014.02.005.
10
Clinical and hemodynamic outcomes in patients with chronic venous insufficiency after oral micronized flavonoid therapy.口服微粉化黄酮类药物治疗慢性静脉功能不全患者的临床和血流动力学结果
Vasc Surg. 2001 Nov-Dec;35(6):443-7. doi: 10.1177/153857440103500604.

引用本文的文献

1
Diagnosis and Management of Pelvic Venous Disorders in Women.女性盆腔静脉疾病的诊断与管理
Cardiovasc Intervent Radiol. 2024 Dec;47(12):1650-1668. doi: 10.1007/s00270-024-03782-1. Epub 2024 Jul 15.
2
Ameliorative potentials of diosmin and hesperidin fractions on chlorpyriphos-induced changes in reproductive hormones, sperm characteristics, and testicular glycogen in male Wistar rats.地奥司明和橙皮苷级分对毒死蜱诱导的雄性 Wistar 大鼠生殖激素、精子特征和睾丸糖原变化的改善潜力。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Nov;397(11):9181-9190. doi: 10.1007/s00210-024-03241-1. Epub 2024 Jun 21.
3
Comprehensive overview of the venous disorder known as pelvic congestion syndrome.
盆腔淤血综合征这一静脉疾病的综合概述。
Ann Med. 2022 Dec;54(1):22-36. doi: 10.1080/07853890.2021.2014556.
4
Clinical Efficacy of Conservative Treatment with Micronized Purified Flavonoid Fraction in Female Patients with Pelvic Congestion Syndrome.微粉化纯化黄酮类化合物治疗女性盆腔淤血综合征的保守治疗临床疗效
Pain Ther. 2021 Dec;10(2):1567-1578. doi: 10.1007/s40122-021-00312-6. Epub 2021 Sep 19.
5
The Effect of Venoactive Drug Therapy on the Development and Severity of Post-Embolization Syndrome in Endovascular Interventions on the Gonadal Veins.血管活性药物治疗对性腺静脉血管内介入术后栓塞后综合征发生及严重程度的影响
J Pers Med. 2021 Jun 7;11(6):521. doi: 10.3390/jpm11060521.
6
Complementary and Alternative (CAM) Treatment Options for Women with Pelvic pain.骨盆疼痛女性的补充和替代(CAM)治疗选择
Curr Phys Med Rehabil Rep. 2020 Sep;8(3):240-248. doi: 10.1007/s40141-020-00264-6. Epub 2020 May 23.
7
Symptoms in Dilating Venous Disease.静脉扩张性疾病的症状。
Curr Cardiol Rev. 2020;16(3):164-172. doi: 10.2174/1573403X16666200312101245.
8
Pelvic vein incompetence: clinical perspectives.盆腔静脉功能不全:临床视角
Vasc Health Risk Manag. 2017 Nov 27;13:439-447. doi: 10.2147/VHRM.S132827. eCollection 2017.
9
Non-surgical interventions for the management of chronic pelvic pain.慢性盆腔疼痛管理的非手术干预措施。
Cochrane Database Syst Rev. 2014 Mar 5;2014(3):CD008797. doi: 10.1002/14651858.CD008797.pub2.
10
Complementary and alternative treatments for chronic pelvic pain.慢性盆腔疼痛的补充和替代治疗。
Curr Pain Headache Rep. 2013 Feb;17(2):316. doi: 10.1007/s11916-012-0316-5.